Literature DB >> 28054827

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Michael J Strong1, Sharon Abrahams2, Laura H Goldstein3, Susan Woolley4, Paula Mclaughlin5, Julie Snowden6, Eneida Mioshi7, Angie Roberts-South8, Michael Benatar9, Tibor HortobáGyi10, Jeffrey Rosenfeld11, Vincenzo Silani12, Paul G Ince13, Martin R Turner14.   

Abstract

This article presents the revised consensus criteria for the diagnosis of frontotemporal dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research workshop on frontotemporal dementia (FTD) and ALS held in London, Canada in June 2015. Since the publication of the Strong criteria, there have been considerable advances in the understanding of the neuropsychological profile of patients with ALS. Not only is the breadth and depth of neuropsychological findings broader than previously recognised - - including deficits in social cognition and language - but mixed deficits may also occur. Evidence now shows that the neuropsychological deficits in ALS are extremely heterogeneous, affecting over 50% of persons with ALS. When present, these deficits significantly and adversely impact patient survival. It is the recognition of this clinical heterogeneity in association with neuroimaging, genetic and neuropathological advances that has led to the current re-conceptualisation that neuropsychological deficits in ALS fall along a spectrum. These revised consensus criteria expand upon those of 2009 and embrace the concept of the frontotemporal spectrum disorder of ALS (ALS-FTSD).

Entities:  

Keywords:  Amyotrophic lateral sclerosis; behaviour; cognition; frontotemporal dementia; genetics; neuropsychology

Mesh:

Year:  2017        PMID: 28054827      PMCID: PMC7409990          DOI: 10.1080/21678421.2016.1267768

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  178 in total

1.  Complex cognitive disruption in motor neuron disease.

Authors:  Rita Moretti; Paola Torre; Rodolfo M Antonello; Nicola Carraro; Giuseppe Cazzato; Antonio Bava
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

2.  Impaired set-shifting in amyotrophic lateral sclerosis: An event-related potential study of executive function.

Authors:  Florian Lange; Maj-Britt Vogts; Caroline Seer; Stefanie Fürkötter; Susanne Abdulla; Reinhard Dengler; Bruno Kopp; Susanne Petri
Journal:  Neuropsychology       Date:  2015-07-13       Impact factor: 3.295

3.  Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS).

Authors:  Susan C Woolley; Michele K York; Dan H Moore; Adriana M Strutt; Jennifer Murphy; Paul E Schulz; Jonathan S Katz
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

4.  Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion.

Authors:  Baber K Khan; Jennifer S Yokoyama; Leonel T Takada; Sharon J Sha; Nicola J Rutherford; Jamie C Fong; Anna M Karydas; Teresa Wu; Robin S Ketelle; Matthew C Baker; Mariely-Dejesus Hernandez; Giovanni Coppola; Daniel H Geschwind; Rosa Rademakers; Suzee E Lee; Howard J Rosen; Gil D Rabinovici; William W Seeley; Katherine P Rankin; Adam L Boxer; Bruce L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-04       Impact factor: 10.154

5.  Beyond the consensus criteria: multiple cognitive profiles in amyotrophic lateral sclerosis?

Authors:  Monica Consonni; Eleonora Catricalà; Eleonora Dalla Bella; Valentina C Gessa; Giuseppe Lauria; Stefano F Cappa
Journal:  Cortex       Date:  2016-04-30       Impact factor: 4.027

6.  Transcultural validation of the ALS-CBS Cognitive Section for the Brazilian population.

Authors:  Lucas M T Branco; Tamires Zanao; Thiago J De Rezende; Raphael F Casseb; Marcio F Balthazar; Susan C Woolley; Marcondes C França
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-08-18       Impact factor: 4.092

Review 7.  The cognitive profile of ALS: a systematic review and meta-analysis update.

Authors:  Emma Beeldman; Joost Raaphorst; Michelle Klein Twennaar; Marianne de Visser; Ben A Schmand; Rob J de Haan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-17       Impact factor: 10.154

8.  Microstructural white matter correlates of emotion recognition impairment in Amyotrophic Lateral Sclerosis.

Authors:  Chiara Crespi; Chiara Cerami; Alessandra Dodich; Nicola Canessa; Marta Arpone; Sandro Iannaccone; Massimo Corbo; Christian Lunetta; Elisa Scola; Andrea Falini; Stefano F Cappa
Journal:  Cortex       Date:  2014-01-18       Impact factor: 4.027

9.  SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.

Authors:  P Wicks; S Abrahams; B Papps; A Al-Chalabi; C E Shaw; P N Leigh; L H Goldstein
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Screening for cognition and behaviour changes in ALS.

Authors:  Sharon Abrahams; Judith Newton; Elaine Niven; Jennifer Foley; Thomas H Bak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-06-19       Impact factor: 4.092

View more
  178 in total

1.  The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives.

Authors:  Marta Pinto-Grau; Orla Hardiman; Niall Pender
Journal:  Neuropsychol Rev       Date:  2018-04-28       Impact factor: 7.444

2.  Apathy and its impact on patient outcome in amyotrophic lateral sclerosis.

Authors:  J Caga; S Hsieh; E Highton-Williamson; M C Zoing; E Ramsey; E Devenney; R M Ahmed; M C Kiernan
Journal:  J Neurol       Date:  2017-11-30       Impact factor: 4.849

3.  ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease.

Authors:  Cinzia Marchi; Maria Pia Adorni; Paolo Caffarra; Nicoletta Ronda; Marco Spallazzi; Federica Barocco; Daniela Galimberti; Franco Bernini; Francesca Zimetti
Journal:  J Lipid Res       Date:  2019-06-05       Impact factor: 5.922

4.  Neurofilaments in pre-symptomatic ALS and the impact of genotype.

Authors:  Michael Benatar; Joanne Wuu; Vittoria Lombardi; Andreas Jeromin; Robert Bowser; Peter M Andersen; Andrea Malaspina
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-08-21       Impact factor: 4.092

Review 5.  Repeat-associated RNA structure and aberrant splicing.

Authors:  Melissa A Hale; Nicholas E Johnson; J Andrew Berglund
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-16       Impact factor: 4.490

6.  Papez Circuit Gray Matter and Episodic Memory in Amyotrophic Lateral Sclerosis and Behavioural Variant Frontotemporal Dementia.

Authors:  Ana Paula Arantes Bueno; Leonardo Cruz de Souza; Walter Hugo Lopez Pinaya; Antônio Lúcio Teixeira; Laura Godoy Rousseff de Prado; Paulo Caramelli; Michael Hornberger; João Ricardo Sato
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

Review 7.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

8.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

9.  A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.

Authors:  Alberto Lleó; David J Irwin; Ignacio Illán-Gala; Corey T McMillan; David A Wolk; Edward B Lee; Vivianna M Van Deerlin; Leslie M Shaw; John Q Trojanowski; Murray Grossman
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

10.  Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Authors:  Zhe Long; Muireann Irish; Olivier Piguet; Matthew C Kiernan; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2019-02-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.